Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sofosbuvir/therapeutic use"'
Autor:
Ana Cláudia Miranda, Rosário Serrão, Josefina Mendez, Patrícia Pacheco, Sónia Rocha, Sara Pinto, Cristina Valente, Ana Paula Reis, André Gomes, Francisco Vale, Rosário Pazos, Rui Sarmento-Castro, Maria José Manata, Rui Pereira, Isabel Germano, Ana Martins
Publikováno v:
Journal of Viral Hepatitis
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Direct-acting antiviral drugs (DAAs) have recently changed the paradigm of hepatitis C therapy, significantly improving treatment response rates, patient life expectancy and quality of life. In Portugal, sofosbuvir (SOF) and SOF/ledipasvir (SOF/LDV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf72d778d4875c57ab343ccaf0dad349
http://europepmc.org/articles/PMC7317188
http://europepmc.org/articles/PMC7317188
Autor:
Smith, David A., Fernandez-Antunez, Carlota, Magri, Andrea, Bowden, Rory, Chaturvedi, Nimisha, Fellay, Jacques, McLauchlan, John, Foster, Graham R., Irving, William L., Simmonds, Peter, Pedergnana, Vincent, Ramirez, Santseharay, Bukh, Jens, Barnes, Eleanor, Ansari, M. Azim, Ball, Jonathan, Brainard, Diana, Burgess, Gary, Cooke, Graham, Dillon, John, Gore, Charles, Guha, Neil, Halford, Rachel, Herath, Cham, Holmes, Chris, Howe, Anita, Hudson, Emma, Irving, William, Khakoo, Salim, Klenerman, Paul, Koletzki, Diana, Martin, Natasha, Massetto, Benedetta, Mbisa, Tamyo, McHutchison, John, McKeating, Jane, Miners, Alec, Murray, Andrea, Shaw, Peter, Spencer, Chris C. A., Targett-Adams, Paul, Thomson, Emma, Vickerman, Peter, Zitzmann, Nicole
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
STOP-HCV Consortium 2021, ' Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure ', Nature Communications, vol. 12, no. 1, 6105 . https://doi.org/10.1038/s41467-021-25649-6
Nature Communications, 2021, 12 (1), pp.6105. ⟨10.1038/s41467-021-25649-6⟩
Nature communications, vol. 12, no. 1, pp. 6105
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
STOP-HCV Consortium 2021, ' Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure ', Nature Communications, vol. 12, no. 1, 6105 . https://doi.org/10.1038/s41467-021-25649-6
Nature Communications, 2021, 12 (1), pp.6105. ⟨10.1038/s41467-021-25649-6⟩
Nature communications, vol. 12, no. 1, pp. 6105
Sofosbuvir is a common therapy in hepatitis C virus infection, which targets the NS5B polymerase. Here, Smith et al. analyze the association between whole genome HCV polymorphisms and sofosbuvir treatment failure and identify three common polymorphis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9cf99c929fe18ff1ccaeb9a812b730
Autor:
Williane Emanuelle Rodrigues Costa, Norma Arteiro Filgueira, André Gustavo da Silva Rezende, Andrea Dória Batista, Poline Maria de Sousa Felix, Edmundo Pessoa de Almeida Lopes, Brivaldo Markman Filho
Publikováno v:
International Journal of Cardiovascular Sciences, Issue: ahead, Published: 23 JUN 2021
International Journal of Cardiovascular Sciences v.35 n.5 2022
International Journal of Cardiovascular Sciences
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
International Journal of Cardiovascular Sciences, Volume: 35, Issue: 5, Pages: 578-584, Published: 23 JUN 2021
International Journal of Cardiovascular Sciences v.35 n.5 2022
International Journal of Cardiovascular Sciences
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
International Journal of Cardiovascular Sciences, Volume: 35, Issue: 5, Pages: 578-584, Published: 23 JUN 2021
Background Chronic Hepatitis C (CHC) therapy with direct-acting antivirals (DAAs) has high efficacy and safety, but some cases of bradyarrhythmias have been described. Objective To evaluate heart rhythm disorders during DAA treatments. Methods Forty-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c60d6d3bb0d107c8e8600c5fabcb1d
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005007206&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005007206&lng=en&tlng=en
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Darragh Duffy, Eric G. Meissner, Henry Masur, Shyam Kottilil, Matthew L. Albert, Jérémie Decalf, Armanda Casrouge
Publikováno v:
PLoS ONE
PLoS ONE, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
PLoS ONE, Vol 10, Iss 7, p e0133236 (2015)
PLoS ONE, Public Library of Science, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
PLoS ONE, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
PLoS ONE, Vol 10, Iss 7, p e0133236 (2015)
PLoS ONE, Public Library of Science, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy. Elevated levels of NH2-terminal truncated CXCL10 (3-77aa), produced by DPP4 cleavage, negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34288c84d102b5e0fb82496371553986
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380964/file/journal.pone.0133236.PDF
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380964/file/journal.pone.0133236.PDF